Literature DB >> 334969

Fc receptor heterogeneity: immunofluorescent studies of B, T, and "third population" lymphocytes in human blood with rabbit IgG b4/anti-b4 complexes.

J B Winfield, P I Lobo, M E Hamilton.   

Abstract

IgG Fc receptors on human peripheral blood lymphocytes (PBL) were characterized by immunofluorescence studies with defined rabbit IgG b4 allotype/anti-allotype complexes. Three discrete types of Fc receptor-bearing cells, totaling approximately 33% of PBL, were identified. Fc receptors of the three types differed in their sensitivity to trypsin and in either absolute or localized density (topography) as determined by variable requirements for anti-IgC cross-linking in order to visualize bound complexes microscopically. The question of additional heterogeneity related to differences in individual Fc receptor affinity for complexed IgG was not approached in this study. Ten to 15% of PBL had pronase-sensitive, trypsin-resistant Fc receptors readily detected by direct immunofluorescence by using large fluorescein-conjugated complexes prepared near equivalence. Double label and lymphocyte fractionation experiments established this population to be largely distinct from suface IgM+ B cells and T cells, and identical to EA Ripley rosette-forming cells. Approximately 50% of surface IgM+ B cells and approximately 10% of T cells had lower density Fc receptors identified by indirect immunofluorescence with small complexes prepared in antigen excess or by cross-linking fluorescein-conjugated complexes with anti-rabbit IgG anti-serum. An additional approximately 15% peripheral T and B cells had very low density Fc receptors detectable by complexing the IgG on the cell surface by sequential incubations of cells with b4 IgG and anti-b4. Fc receptors on B and T cells were sensitive to both pronase and trypsin digestion. The heterogeneity of IgG Fc receptors on different lymphocyte subpopulations as defined by these these experiments may be of relevance for further analysis of normal and abnormal immune function.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 334969

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Comparison of various tests for Fc receptors on different human lymphocyte sub populations.

Authors:  R J Winchester; T Hoffman; M Ferrarini; G D Ross; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

2.  Characterization of a non-T, non-B human lymphocyte (L cell) with use of monoclonal antibodies. Its regulatory role in B lymphocyte function.

Authors:  P I Lobo
Journal:  J Clin Invest       Date:  1981-08       Impact factor: 14.808

3.  Surface markers of complement receptor lymphocytes.

Authors:  G D Ross; R J Winchester; E M Rabellino; T Hoffman
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

4.  Immunologic diagnosis and monitoring of human acute leukemias: a review.

Authors:  M Maheu; M A Baker; J A Falk; R N Taub
Journal:  Am J Pathol       Date:  1981-04       Impact factor: 4.307

5.  Fc receptors on lymphocytes from the blood of rheumatoid arthritis patients and normal controls: a comparison of four Fc receptor assays.

Authors:  R K Sharpin; J D Wilson
Journal:  Clin Exp Immunol       Date:  1981-09       Impact factor: 4.330

6.  Vitamin D metabolites change the phenotype of monoblastic U937 cells.

Authors:  R C Dodd; M S Cohen; S L Newman; T K Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

7.  Human B lymphocytes produce leukocyte interferon after interaction with foreign cells.

Authors:  D A Weigent; M P Langford; E M Smith; J E Blalock; G J Stanton
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

8.  Enhancement of neutrophils function as a result of prior exposure to chemotactic factor.

Authors:  D E Van Epps; M L Garcia
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

9.  Lymphocyte antigens in systemic lupus erythematosus: studies with heterologous antisera.

Authors:  R C Williams; G R Hughes; M L Snaith; H F Parry; E Diao; M F Greaves
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

10.  Breast milk lymphocyte response to K1 antigen of Escherichia coli.

Authors:  M A Keller; J L Turner; J A Stratton; M E Miller
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.